SONUS Pharmaceuticals Elects George Dunbar to Board

SONUS Pharmaceuticals, Inc., (Bothell, Wash.) has elected George W. Dunbar, Jr. to its board of directors. Dunbar is president, CEO and a director of Metra Biosystems, Inc., a company headquartered in Mountain View, Calif. that develops new diagnostics and medical devices for detection and management of bone and joint diseases.

"We are fortunate to have George's in-depth knowledge of the biotechnology and pharmaceutical industry," said Steven C. Quay, M.D., Ph.D., president and CEO of SONUS.

From 1988 until 1991, Dunbar was the vice president of licensing and business development for the Ares-Serono Group, a Swiss health care company. From 1974 until 1987, he held various senior management positions with Amersham International, a health care and life sciences company. Dunbar also served as Amersham's general manager of Pacific Rim markets and eastern regional operations.

Dunbar holds a bachelor's degree in electrical engineering and an MBA from Auburn University.

SONUS Pharmaceuticals, Inc. is engaged in the research and development of ultrasound contrast agents and drug delivery systems based on its PhaseShift and fluorocarbon technology.